Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Grimes

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Infectious Diseases and Therapy|July 8, 2025
Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and CanadaTodd Wolynn, John B Grimes, Sayali Nerurkar, et al.
Journal of the American Academy of Dermatology|October 5, 2023
Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCLMadeline J Hooper, Francesca L Veon, Gail L Enriquez, et al.
Blood|June 20, 2020
Racial variation in ITP prevalence and chronic disease phenotype suggests biological differencesTaylor Olmsted Kim, Amanda B Grimes, Susan E Kirk, et al.
Pediatric Blood & Cancer|January 10, 2026
Pediatric Evans Syndrome Diagnostic Evaluation Patterns: Survey Results From the Pediatric ITP Consortium of North AmericaTaylor Olmsted Kim, Kirsty Hillier, Elizabeth Gunn, et al.
Animal Bioscience|June 28, 2024
Influence of long-term supplementation of a formulated botanical blend on growth performance and carcass traits in feedlot steersThiago Lauro Maia Ribeiro, Becca B Grimes Francis, Erin R DeHaan, et al.
Leukemia|October 6, 2000
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cellsC T Jordan, D Upchurch, S J Szilvassy, et al.
Journal of Neurotrauma|August 24, 2013
Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology WorkgroupRamon Diaz-Arrastia, Patrick M Kochanek, Peter Bergold, et al.
Blood|February 3, 2026
Predicting Development of Pediatric Chronic Immune Thrombocytopenia at Disease Onset Using a Statistical Risk ModelKirsty Hillier, Mark Zobeck, Derek MacMath, et al.
Blood Advances|August 27, 2024
Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopeniaTaylor Olmsted Kim, Jennifer M Geris, Jonathan M Flanagan, et al.
Blood Advances|July 26, 2024
What is in a name: defining pediatric refractory ITPTaizo A Nakano, Amanda B Grimes, Robert J Klaassen, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Infectious Diseases and Therapy|July 8, 2025
Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and CanadaTodd Wolynn, John B Grimes, Sayali Nerurkar, et al.
Journal of the American Academy of Dermatology|October 5, 2023
Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCLMadeline J Hooper, Francesca L Veon, Gail L Enriquez, et al.
Blood|June 20, 2020
Racial variation in ITP prevalence and chronic disease phenotype suggests biological differencesTaylor Olmsted Kim, Amanda B Grimes, Susan E Kirk, et al.
Pediatric Blood & Cancer|January 10, 2026
Pediatric Evans Syndrome Diagnostic Evaluation Patterns: Survey Results From the Pediatric ITP Consortium of North AmericaTaylor Olmsted Kim, Kirsty Hillier, Elizabeth Gunn, et al.
Animal Bioscience|June 28, 2024
Influence of long-term supplementation of a formulated botanical blend on growth performance and carcass traits in feedlot steersThiago Lauro Maia Ribeiro, Becca B Grimes Francis, Erin R DeHaan, et al.
Leukemia|October 6, 2000
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cellsC T Jordan, D Upchurch, S J Szilvassy, et al.
Journal of Neurotrauma|August 24, 2013
Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology WorkgroupRamon Diaz-Arrastia, Patrick M Kochanek, Peter Bergold, et al.
Blood|February 3, 2026
Predicting Development of Pediatric Chronic Immune Thrombocytopenia at Disease Onset Using a Statistical Risk ModelKirsty Hillier, Mark Zobeck, Derek MacMath, et al.
Blood Advances|August 27, 2024
Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopeniaTaylor Olmsted Kim, Jennifer M Geris, Jonathan M Flanagan, et al.
Blood Advances|July 26, 2024
What is in a name: defining pediatric refractory ITPTaizo A Nakano, Amanda B Grimes, Robert J Klaassen, et al.
Pageof 9